triphenyltetrazolium has been researched along with Ventricular Fibrillation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crockett, TR; Gray, GA; Kane, KA; Wainwright, CL | 1 |
| Cohen, MV; Downey, JM; Miki, T; Swafford, AN | 1 |
2 other study(ies) available for triphenyltetrazolium and Ventricular Fibrillation
| Article | Year |
|---|---|
Sarafotoxin 6c (S6c) reduces infarct size and preserves mRNA for the ETB receptor in the ischemic/reperfused myocardium of anesthetized rats.
Topics: Animals; Blood Pressure; Coronary Disease; Disease Models, Animal; Drug Administration Schedule; Evans Blue; Glyceraldehyde-3-Phosphate Dehydrogenases; Injections, Intravenous; Ligation; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Time Factors; Ventricular Fibrillation; Viper Venoms | 2004 |
Second window of protection against infarction in conscious rabbits: real or artifactual.
Topics: Animals; Coloring Agents; Female; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Rabbits; Tetrazolium Salts; Time Factors; Ventricular Fibrillation | 1999 |